Skip to main content

Advertisement

Log in

Establishment of a new predictive model for the recurrence of upper urinary tract stones

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To construct a nomogram for evaluation of the recurrence risk of upper urinary tract stones in patients.

Methods

We retrospectively reviewed the clinical data of 657 patients with upper urinary tract stones and divided them into stone recurrence group and non-recurrence group. Blood routine, urine routine, biochemical, and urological CT examinations were searched from the electronic medical record, relevant clinical data were collected, including age, BMI, stones number and location, maximum diameter, hyperglycemia, hypertension, and relevant blood and urine parameters. The Wilcoxon rank-sum test, independent sample t test, and Chi-square test were used to preliminarily analyze the data of the two groups, then LASSO and logistic regression analysis were used to find out the significant difference indicators. Finally, R software was used to draw a nomogram to construct the model, and ROC curve was drawn to evaluate the sensitivity and specificity.

Results

The results showed that multiple stones (OR: 1.832, 95% CI 1.240–2.706), bilateral stones (OR: 1.779, 95% CI 1.226–2.582), kidney stones (OR: 3.268, 95% CI 1.638–6.518), and kidney ureteral stones (OR: 3.375, 95% CI 1.649–6.906) were high risk factors. And the stone recurrence risk was positively correlated with creatinine (OR: 1.012, 95% CI 1.006–1.018), urine pH (OR: 1.967, 95% CI 1.343–2.883), Apo B (OR: 4.189, 95% CI 1.985–8.841) and negatively correlated with serum phosphorus (OR: 0.282, 95% CI 0.109–0.728). In addition, the sensitivity and specificity of the prediction model were 73.08% and 61.25%, diagnosis values were greater than any single variable.

Conclusion

The nomogram model can effectively evaluate the recurrence risk of upper urinary stones, especially suitable for stone postoperative patients, to help reduce the possibility of postoperative stone recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

Data are available with permission from the corresponding author.

References

  1. Tzelves L, Türk C, Skolarikos A (2021) European association of urology urolithiasis guidelines: where are we going? Eur Urol Focus. https://doi.org/10.1016/j.euf.2020.09.011

    Article  PubMed  Google Scholar 

  2. Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, Wu W, Liu Y, Cui Z, Zhao Z, Qin J, Zeng T, Liu Y, Duan X, Mai X, Yang Z, Kong Z, Zhang T, Cai C, Shao Y, Yue Z, Li S, Ding J, Tang S, Ye Z (2017) Prevalence of kidney stones in china: an ultrasonography based cross-sectional study. BJU Int. https://doi.org/10.1111/bju.13828

    Article  PubMed  Google Scholar 

  3. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol. https://doi.org/10.1007/s00345-017-2008-6

    Article  PubMed  Google Scholar 

  4. Milligan M, Berent AC (2019) Medical and interventional management of upper urinary tract uroliths. Vet Clin North Ame. https://doi.org/10.1016/j.cvsm.2018.11.004

    Article  Google Scholar 

  5. Ziemba JB, Matlaga BR (2017) Epidemiology and economics of nephrolithiasis. Investig Clin Urol. https://doi.org/10.4111/icu.2017.58.5.299

    Article  PubMed  PubMed Central  Google Scholar 

  6. Antonelli JA, Maalouf NM, Pearle MS, Lotan Y (2014) Use of the national health and nutrition examination survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 66(4):724–729. https://doi.org/10.1016/j.eururo.2014.06.036

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ingvarsdottir SE, Indridason OS, Palsson R, Edvardsson VO (2020) Stone recurrence among childhood kidney stone formers: results of a nationwide study in iceland. Urolithiasis. https://doi.org/10.1007/s00240-020-01179-6

    Article  PubMed  Google Scholar 

  8. Wang Z, Zhang Y, Zhang J, Deng Q, Liang H (2021) Recent advances on the mechanisms of kidney stone formation (review). Int J Mol Med. https://doi.org/10.3892/ijmm.2021.4982

    Article  PubMed  PubMed Central  Google Scholar 

  9. Daudon M, Jungers P, Bazin D, Williams JC (2018) Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis. https://doi.org/10.1007/s00240-018-1043-0

    Article  PubMed  PubMed Central  Google Scholar 

  10. Daudon M, Dessombz A, Frochot V, Letavernier E, Haymann J, Jungers P, Bazin D (2016) Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis. C R Chim. https://doi.org/10.1016/j.crci.2016.05.008

    Article  Google Scholar 

  11. Baowaidan F, Zugail AS, Lyoubi Y, Culty T, Lebdai S, Brassart E, Bigot P (2022) Incidence and risk factors for urolithiasis recurrence after endourological management of kidney stones: a retrospective single-centre study. Prog Urol. https://doi.org/10.1016/j.purol.2022.02.010

    Article  PubMed  Google Scholar 

  12. Ding Q, Ouyang J, Fan B, Cao C, Fan Z, Ding L, Li F, Tu W, Jin X, Wang J, Shi Y (2019) Association between dyslipidemia and nephrolithiasis risk in a chinese population. Urol Int. https://doi.org/10.1159/000496208

    Article  PubMed  Google Scholar 

  13. Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B (2017) Age, body mass index, and gender predict 24-hour urine parameters in recurrent idiopathic calcium oxalate stone formers. J Endourol. https://doi.org/10.1089/end.2017.0352

    Article  PubMed  Google Scholar 

  14. Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y, Chen J, Chen D, Wu J, Shen N, Zhu S, Xue B, Xu X (2022) Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol. https://doi.org/10.1186/s12894-022-01017-4

    Article  PubMed  PubMed Central  Google Scholar 

  15. Thongprayoon C, Krambeck AE, Rule AD (2020) Determining the true burden of kidney stone disease. Nat Rev Nephrol. https://doi.org/10.1038/s41581-020-0320-7

    Article  PubMed  Google Scholar 

  16. Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C (2015) Metabolic evaluation and recurrence prevention for urinary stone patients: eau guidelines. Eur Urol. https://doi.org/10.1016/j.eururo.2014.10.029

    Article  PubMed  Google Scholar 

  17. Tiselius H (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis. https://doi.org/10.1007/s00240-015-0840-y

    Article  PubMed  Google Scholar 

  18. Alhamzawi R, Alhamzawi A, Mohammad Ali HT (2019) New gibbs sampling methods for bayesian regularized quantile regression. Comput Biol Med. https://doi.org/10.1016/j.compbiomed.2019.05.011

    Article  PubMed  Google Scholar 

  19. Meurer WJ, Tolles J (2017) Logistic regression diagnostics: understanding how well a model predicts outcomes. JAMA. https://doi.org/10.1001/jama.2016.20441

    Article  PubMed  Google Scholar 

  20. Park SY (2018) Nomogram: an analogue tool to deliver digital knowledge. J Thoracic Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2017.12.107

    Article  Google Scholar 

  21. Ang X, Jiang Y, Cai Z, Zhou Q, Li M, Zhang B, Chen W, Chen L, Zhang X (2021) A nomogram for bladder pain syndrome/interstitial cystitis based on netrin-1. Int Urol Nephrol. https://doi.org/10.1007/s11255-021-03084-2

    Article  PubMed  PubMed Central  Google Scholar 

  22. Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. https://doi.org/10.1016/j.eururo.2018.08.038

    Article  PubMed  PubMed Central  Google Scholar 

  23. Soghra R, Armin R, Jeffrey IM, Fatemeh M, Yekta R, Manouchehr N, Alireza E (2021) Ldl/apo b ratio predict coronary heart disease in type 2 diabetes independent of ascvd risk score: a case-cohort study. Nutr Metab Cardiovasc Dis. https://doi.org/10.1016/j.numecd.2021.01.013

    Article  Google Scholar 

Download references

Acknowledgements

We were supported by the Natural Science Foundation of Anhui Province (1908085MH246), and the National Natural Science Foundation of China (82070724).

Author information

Authors and Affiliations

Authors

Contributions

KX and professor Hao were in charge of designing the project, KX and YX were in charge of writing, KX and QQ were in charge of statistical analysis, QH, JZ, and RY were in charge of collecting data. All the authors reviewed the manuscript.

Corresponding author

Correspondence to Zongyao Hao.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Ethical approval

This article was a retrospective study, and supported by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University, the ethical batch number was Quick-PJ2022-14-32. Patient consent were not required in accordance with local or national guidelines.

Consent for publication

All authors supported the publication of manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

11255_2023_3698_MOESM1_ESM.tif

Supplementary file1 Urea, creatinine (Cr), cystatin C, serum phosphorus (P), apo B, and urine pH expression levels in the stone recurrence and non-recurrence groups. A-E. The expression level of urea, creatinine (Cr), cystatin C, apo B, and urine pH were higher in stone recurrence group than stone non-recurrence group; F. Serum phosphorus (P) levels were lower in stone recurrence group than stone non-recurrence group (TIF 1885 KB)

11255_2023_3698_MOESM2_ESM.tif

Supplementary file2 Nomogram of upper urinary tract stones prediction model including serum creatinine and serum phosphate as mg/dl (TIF 17276 KB)

Supplementary file3 Nomogram of upper urinary tract stones prediction model without Apo B (TIF 1943 KB)

Supplementary file4 ROC curves of upper urinary tract stones prediction model without Apo B (TIF 7090 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xia, K., Xu, Y., Qi, Q. et al. Establishment of a new predictive model for the recurrence of upper urinary tract stones. Int Urol Nephrol 55, 2411–2420 (2023). https://doi.org/10.1007/s11255-023-03698-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03698-8

Keywords

Navigation